Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1056)
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
3,314
Price
$212.06
Total Value
$702.76K
Shares Held After
55,907
% of Holdings
5.6%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
4,500
Price
$211.34
Total Value
$951.04K
Shares Held After
59,221
% of Holdings
7.1%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
2,540
Price
$210.26
Total Value
$534.07K
Shares Held After
63,721
% of Holdings
3.8%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
25,817
Price
$209.25
Total Value
$5.40M
Shares Held After
66,261
% of Holdings
28.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
17,323
Price
$208.37
Total Value
$3.61M
Shares Held After
92,078
% of Holdings
15.8%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
3,400
Price
$207.24
Total Value
$704.60K
Shares Held After
109,401
% of Holdings
3.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,871
Price
$15.00
Total Value
$43.07K
Shares Held After
90,180
% of Holdings
3.1%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
716,369
Price
$1.77
Total Value
$1.27M
Shares Held After
4,746,444
% of Holdings
15.1%
Arcus Biosciences, Inc. (RCUS)
Azoy Alexander — Chief Accounting Officer
Shares
2,827
Price
$30.00
Total Value
$84.81K
Shares Held After
39,581
% of Holdings
6.7%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
4,345
Price
$11.89
Total Value
$51.66K
Shares Held After
169,269
% of Holdings
2.5%
Intellia Therapeutics, Inc. (NTLA)
LEONARD JOHN M — Director
Shares
2,785
Price
$13.00
Total Value
$36.20K
Shares Held After
1,147,064
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$527.71
Total Value
$105.54K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
45
Price
$526.47
Total Value
$23.69K
Shares Held After
324,643
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
235
Price
$525.42
Total Value
$123.47K
Shares Held After
324,688
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$524.35
Total Value
$327.72K
Shares Held After
324,923
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
455
Price
$523.62
Total Value
$238.25K
Shares Held After
325,548
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
669
Price
$522.29
Total Value
$349.41K
Shares Held After
326,003
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
371
Price
$521.28
Total Value
$193.40K
Shares Held After
326,672
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$520.03
Total Value
$228.81K
Shares Held After
327,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
837
Price
$519.09
Total Value
$434.47K
Shares Held After
327,483
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$518.14
Total Value
$558.03K
Shares Held After
328,320
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
773
Price
$517.07
Total Value
$399.69K
Shares Held After
329,397
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,689
Price
$516.15
Total Value
$871.78K
Shares Held After
330,170
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
624
Price
$515.26
Total Value
$321.52K
Shares Held After
331,859
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
271
Price
$513.85
Total Value
$139.25K
Shares Held After
332,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,189
Price
$512.71
Total Value
$609.62K
Shares Held After
332,754
% of Holdings
0.4%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
20,000
Price
$0.65
Total Value
$13.00K
Shares Held After
73,533
% of Holdings
27.2%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
144,756
Price
$36.48
Total Value
$5.28M
Shares Held After
18,630,739
% of Holdings
0.8%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
21,055
Price
$1.60
Total Value
$33.60K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
20,553
Price
$1.59
Total Value
$32.78K
Shares Held After
48,750
% of Holdings
29.7%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
32,018
Price
$4.50
Total Value
$144.08K
Shares Held After
2,433,280
% of Holdings
1.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Curran Terrie — Director
Shares
1,072
Price
$26.04
Total Value
$27.91K
Shares Held After
23,526
% of Holdings
4.4%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
11,899
Price
$1.37
Total Value
$16.30K
Shares Held After
600,117
% of Holdings
2.0%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
202,124
Price
$1.78
Total Value
$359.54K
Shares Held After
4,030,075
% of Holdings
5.0%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
60,677
Price
$47.05
Total Value
$2.85M
Shares Held After
59,086
% of Holdings
50.7%
Intellia Therapeutics, Inc. (NTLA)
LEONARD JOHN M — Director
Shares
19,890
Price
$12.60
Total Value
$250.61K
Shares Held After
1,149,849
% of Holdings
1.7%
Tonix Pharmaceuticals Holding Corp. (TNXP)
BAGGER RICHARD H — Director
Shares
1,000
Price
$12.60
Total Value
$12.60K
Shares Held After
1,000
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
17,519
Price
$37.30
Total Value
$653.46K
Shares Held After
18,630,739
% of Holdings
0.1%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
66,711
Price
$1.51
Total Value
$101.00K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
67,741
Price
$1.51
Total Value
$102.59K
Shares Held After
48,750
% of Holdings
58.2%
OMEROS CORP (OMER)
Cable Thomas J. — Director
Shares
15,000
Price
$18.45
Total Value
$276.77K
Shares Held After
35,067
% of Holdings
30.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
691
Price
$72.92
Total Value
$50.39K
Shares Held After
1,361,594
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
2,390
Price
$71.88
Total Value
$171.79K
Shares Held After
1,362,285
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,419
Price
$70.78
Total Value
$666.68K
Shares Held After
1,364,675
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
193
Price
$526.97
Total Value
$101.71K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$525.10
Total Value
$126.02K
Shares Held After
324,636
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$523.26
Total Value
$418.61K
Shares Held After
324,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
960
Price
$522.37
Total Value
$501.48K
Shares Held After
325,676
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,470
Price
$521.39
Total Value
$1.29M
Shares Held After
326,636
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,357
Price
$520.46
Total Value
$1.23M
Shares Held After
329,106
% of Holdings
0.7%
Showing 251–300 of 1056 transactions (page 6 of 22)